|
Match
|
Document |
Document Title |
|
|
8182833 |
Method and kit for reducing the symptoms of peripheral vascular disease with topical progesterone
A method for reducing the symptoms of peripheral vascular disease and for improving peripheral circulation wherein a progestin is administered to a subject in need thereof.
|
|
|
8183427 |
Biodegradable absorbents and methods of preparation
A biodegradable microfiber absorbent comprises a substantially homogeneous mixture of at least one hydrophilic polymer and at least one biodegradable polymer. The absorbent can be prepared by an...
|
|
|
8172815 |
Device for withdrawing or administrating a substance and method of a device
A device includes a plurality of skin penetrating devices for delivering or withdrawing a substance through the skin of a patient. The device has a support formed with a top and bottom end and a...
|
|
|
8173155 |
Adhesive patch
The present invention relates an adhesive patch comprising a backing layer and an adhesive layer that contains a drug, wherein the adhesive layer contains a mixed adhesive base containing a...
|
|
|
8173156 |
Method for avoiding crystallization of anti-inflammatory agent in plaster formulation
An anti-inflammatory-containing plaster is provided. The anti-inflammatory-containing plaster may include, e.g., a styrene-isoprene-styrene block copolymer, a high molecular weight polyisobutylene,...
|
|
|
8163725 |
Gel compositions and methods of use
Improved topical gel compositions for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are substantially free of methylparaben crystalline...
|
|
|
8158145 |
Percutaneous absorption type plaster
A transdermal patch comprising a backing 2 and an adhesive layer 3 laminated on the backing 2, wherein the adhesive layer 3 comprises a rosin-based resin and petroleum resin as a tackifier, the...
|
|
|
8158845 |
Wound dressing
A wound dressing comprises in combination (i) a first wound contact layer which preferably has a positive effect on the healing of the wound, and (ii) a second layer of greater hydrophilicity than...
|
|
|
8153151 |
Composition and method for controlling drug delivery from silicone adhesive blends
Compositions and methods for controlling transdermal drug delivery, particularly of amine-functional and basic drugs, comprising a blend of a first silicone-based polymer having a reduced silanol...
|
|
|
8155738 |
Composition and device structure for iontophoresis
Device structure 100 for iontophoresis provides electrode 101 and electrically conductive layer 102. Electrically conductive layer 102 contains active ingredient D and basic water swelling...
|
|
|
8146741 |
Blister package
A blister package comprises a blister and a cover sheet, and the blister has a groove formed in an outer edge section of the blister. The outer edge section of the blister includes an outer region...
|
|
|
8133505 |
Transdermal delivery system for dried particulate or lyophilized medications
The present invention provides a system for transdermal delivery of dried or lyophilized pharmaceutical compositions and methods using thereof. The system comprises an apparatus for facilitating...
|
|
|
8127926 |
Patch package structure
A patch package structure which includes: a package including a first sheet material which is planar and a second sheet material which has been molded, a peripheral area of the first sheet material...
|
|
|
8128964 |
Transdermal pharmaceutical delivery composition
A pharmaceutically delivery system is described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide at the skin surface. The...
|
|
|
8124122 |
Female hormone-containing patch
Provided herein is a female hormone-containing patch wherein an active ingredient is highly soluble in a pressure-sensitive adhesive layer and the active ingredient is not adsorbed to a backing,...
|
|
|
8114434 |
Diclofenac sodium patches for topical treatment of pain
The invention provides an analgesic anti-inflammatory patch of a hydrophobic type for topical application containing, in a Pressure Sensitive Adhesive(PSA), diclofenac sodium, pyrrolidone or a...
|
|
|
8114442 |
Transdermal pharmaceutical delivery compositions
A pharmaceutically delivery system and method of use therefor are described comprising a pharmaceutically active agent and acidified nitrite as an agent to produce local production of nitric oxide...
|
|
|
8105624 |
Topical patch for pain relief using cooling agent
Topical patch preparations that contain an odorless physiological cooling agent, and methods for using the same are provided. The subject topical patch preparations are made up of an adhesive gel...
|
|
|
8092827 |
Medical non-crosslinked pressure-sensitive adhesive composition, medical adhesive sheet employing the same, and process for producing medical non-crosslinked pressure-sensitive adhesive composition
A medical non-crosslinked pressure-sensitive adhesive composition which not only has relatively high resistance to water during perspiration or the like and shows a sufficient skin adhesive force,...
|
|
|
8080261 |
1-chloro-2,4-dinitrobenzene non-aqueous gel compositions and methods for using the same
Gel compositions that contain 1-dichloro-2,4-dinitrobenzene (DNCB) are provided. Embodiments of the subject gel compositions include DNCB, an organic solvent and a viscosity agent, wherein the...
|
|
|
8075912 |
Autodestructive transdermal therapeutic system
The invention relates to a transdermal therapeutic system (TTS), preferably in the form of a transdermal plaster, that contains an active substance and an agent which can destroy the active...
|
|
|
8075911 |
Transparent transdermal nicotine delivery devices
A transparent transdermal delivery device for delivering nicotine which has an Opacity Index of less than 48.6%.
|
|
|
8071075 |
Dermal penetration enhancers and drug delivery systems involving the same
The invention relates to a method for treatment or prophylaxis of a disease or condition in an animal comprising administering to a mucosal membrane of said animal in need of such treatment a...
|
|
|
8071126 |
Percutaneous absorption type patch
A percutaneous absorption type patch adapted to be applied to a skin surface of a patient. The percutaneous absorption type patch comprises: a stratum-corneum release member constituted from a...
|
|
|
8071125 |
Transdermal patch containing isosorbide dinitrate and bisoprolol
This invention relates to a transdermal patch in the form of a layer complex, comprising a backing layer, a drug-reservoir layer comprising pharmacologically active ingredients and pharmaceutically...
|
|
|
8053427 |
Brimonidine gel composition
Improved topical gel compositions, such as those containing brimonidine, for the treatment of skin disorders are described. The gel compositions contain carbomer and methylparaben, and are...
|
|
|
8048927 |
Treatment and prevention of benign breast disease with 4-hydroxy tamoxifen
The present invention provides methods for treating and preventing benign breast disease by administering 4-hydroxy tamoxifen to a patient. When percutaneously administered to a patient's breasts,...
|
|
|
8039023 |
Composition for relief of menstrual cramps and muscle cramps
A composition is disclosed which provides relief from menstrual cramps and muscle cramps within three to seven minutes after ingestion. The composition is preferably a mixture in the form of an...
|
|
|
8034374 |
Patch containing nonsteroidal anti-inflammatory and analgesic agent
An adhesive patch containing a non-steroidal anti-inflammatory agent, comprising a support and an adhesive layer laminated on this support, wherein the adhesive layer contains a non-steroidal...
|
|
|
8029820 |
Patches containing tulobuterol
A patch containing tulobuterol in the low concentration and having the stable release-controllability, prepared by laminating an adhesive layer consisting of a rubber, an adhesive resin and a...
|
|
|
8025886 |
Modified VEGF-A with improved angiogenic properties
The present invention is directed to methods and compositions for making and using chimeric polypeptides that comprise a VEGFR-2 ligand. The chimeric molecules of the present invention retain...
|
|
|
8025898 |
Enhanced drug delivery in transdermal systems
A composition for transdermal administration resulting from an admixture includes: a therapeutically effective amount of a drug that includes a parent drug and a prodrug; and a pharmaceutically...
|
|
|
8022266 |
Method of treating a wound utilizing suction
A therapeutic device for promoting the healing of a wound in a mammal is disclosed. An exemplary device comprises a permeable structure having a plurality of depressions formed in a surface...
|
|
|
8016810 |
Transdermal delivery system for cosmetic agents
An intradermal or transdermal delivery system for topical administration of cosmetic agents, particularly water-soluble, poorly water-soluble, or water-insoluble cosmetic agents, in conjunction...
|
|
|
8017146 |
Transdermal delivery system with two superimposed adhesive layers having different affinities to the active substance comprised
A device for the transdermal delivery of a pharmacologically active substance has first and second superimposed mutually contacting adhesive layers (2, 3). The first layer (3) is in use brought...
|
|
|
7993671 |
Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures
A transdermal composition is disclosed which contains a blend of one or more polymers, one or more drugs, at least one of which has a low molecular weight and is liquid at or about room...
|
|
|
7993654 |
Self-adhesive polymer matrix containing sea algae extract
A self-adhesive polymer matrix which comprises a polymer that forms a gel in water, water, a sea algae extract, and a monohydric or polyhydric alcohol.
|
|
|
7994382 |
Application system for a plaster containing an active ingredient and a controlled-release agent for said active ingredient
The present invention relates to an application system for an active ingredient release system, comprising a film-form application strip, which is in each case bonded detachably to an active...
|
|
|
7988991 |
Adhesive patch
A patch agent of the present invention comprises a support, and an adhesive layer laid on the support and containing an adhesive base and a drug, wherein the adhesive base contains an acrylic...
|
|
|
7988673 |
Protective dressing and methods of use thereof
A protective device having a substantially rigid casing for placement on a patient's skin, wherein the casing has a hollow interior facing the patient's skin and a lip. The casing can be spanned...
|
|
|
7976867 |
Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
A dermal, transdermal, mucosal or transmucosal delivery device is provided. The device includes a backing layer, defining an ingredient containing reservoir, a cover for the reservoir having at...
|
|
|
7979118 |
Low frequency generation poultice
A low frequency generating poultice includes a poultice sheet; a contact fabric that is adhered to a non-medicated surface of the poultice sheet; a release sheet that is attached to a medicated...
|
|
|
7964213 |
Patch and production method thereof
The present invention relates to a patch containing a substrate, a non-crosslinked adhesive layer (A) containing a drug laminated on one surface of the substrate and a crosslinked adhesive layer...
|
|
|
7955677 |
Two-sided non-stick release film
Assemblies for the adhesive attachment to the skin or mucosa of a host are disclosed. The assembly or transdermal patch includes an outer backing layer, a first layer of adhesive on the inner...
|
|
|
7951853 |
Polymer-based antimicrobial agents, methods of making said agents, and products incorporating said agents
The present invention relates to antimicrobial agents, methods for the production of these agents, and the use of these agents. The antimicrobial agent of the present invention includes a...
|
|
|
7951395 |
Dermal application system for aminolaevulinic acid
The invention relates to a dermal for aminolaevulinic acid, wherein a self-adhesive matrix system is used containing crystalline aminolaevulinic acids.
|
|
|
7947304 |
Human growth hormone patch formulations
The invention encompasses a transdermal patch formulation comprising hGH, at least one sugar, one amino acid or polyol, and a buffer, wherein the buffer maintains the pH of the formulation in the...
|
|
|
7939100 |
Tulobuterol adhesive patch
The present invention provides a tulobuterol adhesive patch comprising (a) a support, (b) an acrylic pressure-sensitive adhesive layer containing the percutaneously absorbing drug tulobuterol and...
|
|
|
7935093 |
Disinfectant delivery system and method of providing alcohol-free disinfection
A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an...
|
|
|
7923042 |
Medicated gauze
The present invention relates to a medicated gauze containing as active ingredient, aliantoin, a Centella asiatica extract and, optionally, an Urtica dioica extract.
|